Get the latest Science News and Discoveries

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

None

Get the Android app

Or read this on ScienceDaily

Read more on:

Photo of KRAS

KRAS

Related news:

Study shows promise of new anti-KRAS drug for pancreatic cancer

Targeted drug achieves 43% response rate in KRAS-mutated lung cancer

New approach for cell therapy shows potential against solid tumors with KRAS mutations

« CRISPR-Cas3 gene editing system restores dystrophin function in stem cells derived from patients with Duchenne muscular dystrophy

Japan will be the latest country to aim for the moon this weekend, just days after a Russian spacecraft collided with the lunar surface and India’s Chandrayaan-3 landed near its south pole. »